These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34641931)
21. A rare cause of postmenopausal hyperandrogenism. De Vis M; Brock S; Cosyns S; Velkeniers B BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33414114 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound features and clinical outcome of patients with malignant ovarian masses diagnosed during pregnancy: experience of a gynecological oncology ultrasound center. Moro F; Mascilini F; Pasciuto T; Leombroni M; Li Destri M; De Blasis I; Garofalo S; Scambia G; Testa AC Int J Gynecol Cancer; 2019 Sep; 29(7):1182-1194. PubMed ID: 31326950 [TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report. Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927 [TBL] [Abstract][Full Text] [Related]
34. A new sonomorphologic scoring-system (Mainz score) for the assessment of ovarian tumors using transvaginal ultrasonography. Part II: A comparison between the scoring-system and the assessment by an experienced sonographer in postmenopausal women. Weber G; Merz E; Bahlmann F; Leber AM Ultraschall Med; 1999 Feb; 20(1):2-8. PubMed ID: 10226339 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of ovarian tumors in postmenopausal women by transvaginal sonography. Osmers RG; Osmers M; von Maydell B; Wagner B; Kuhn W Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):81-8. PubMed ID: 9550206 [TBL] [Abstract][Full Text] [Related]
36. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325 [TBL] [Abstract][Full Text] [Related]
37. Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. Mai PL; Miller A; Black A; Falk RT; Boggess JF; Tucker K; Stuckey AR; Rodriguez GC; Wong C; Amatruda TT; Wilkinson KJ; Modesitt SC; Yamada SD; Bixel KL; Glaser GE; Rose PG; Greene MH; Sherman ME Am J Obstet Gynecol; 2022 Jul; 227(1):61.e1-61.e18. PubMed ID: 35216968 [TBL] [Abstract][Full Text] [Related]
38. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867 [TBL] [Abstract][Full Text] [Related]
39. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women. Bahaeldein E; Brassill MJ Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153 [TBL] [Abstract][Full Text] [Related]
40. Postmenopausal Hyperandrogenism Associated With Synchronous Ovarian Brenner Tumor, Bilateral Leydig Cell Tumor, and Adrenal Mass. Salim M; Dasaraju S; Erickson B; Khalifa M; Burmeister LA Cureus; 2024 Mar; 16(3):e55334. PubMed ID: 38559537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]